Albumin Reduces Paracentesis-Induced Circulatory Dysfunction and Reduces Death and Renal Impairment among Patients with Cirrhosis and Infection: A Systematic Review and Meta-Analysis
Open Access
- 8 October 2013
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-8
Abstract
Background.Studies have suggested that albumin has a value in cirrhotic patients undergoing paracentesis but its value in infection and sepsis is less clear. We planned to perform a meta-analysis of the risk of adverse outcomes in cirrhotic patients with and without albumin use.Methods.We searched MEDLINE and EMBASE in January 2013 for randomized studies of cirrhotic patients that reported the risk of adverse events and mortality with albumin and no albumin exposure. We performed random effects meta-analysis and assessed heterogeneity using theI2statistic.Results.Our review included 16 studies covering 1,518 patients. The use of albumin in paracentesis was associated with significantly reduced risk of paracentesis-induced circulatory dysfunction (OR 0.26 95%, CI 0.08–0.93) and there was a nonsignificant difference in death, encephalopathy, hyponatraemia, readmission, and renal impairment. Compared to the other volume expanders, albumin use showed no difference in clinical outcomes. In cirrhotic patients with any infection, there was a significant reduction in mortality (OR 0.46 95%, CI 0.25–0.86) and renal impairment (OR 0.34 95%, CI 0.15–0.75) when albumin was used.Conclusion.The use of albumin in cirrhotic patients is valuable in patients with any infection and it reduces the risk of circulatory dysfunction among patients undergoing paracentesis.Keywords
This publication has 33 references indexed in Scilit:
- Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled studyJournal of Hepatology, 2012
- Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial PeritonitisClinical Gastroenterology and Hepatology, 2011
- Severe sepsis in cirrhosis†Hepatology, 2009
- Management of adult patients with ascites due to cirrhosisHepatology, 2009
- Bacterial Infections, Sepsis, and Multiorgan Failure in CirrhosisSeminars in Liver Disease, 2008
- Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitisJournal of Hepatology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Effect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitisChinese Journal of Digestive Diseases, 2002
- Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trialLiver International, 1993
- Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascitesJournal of Hepatology, 1992